View |
|
DR-XY43854
|
Docetaxel
|
Doxestad
|
20mg/mL
|
Concentrate for Solution for Infusion
|
Antineoplastic
|
Actavis Italy S.p.A.
|
Italy
|
Initial (Variation)
|
13 September 2022
|
13 September 2027
|
View |
|
DR-XY43859
|
Azithromycin (as Dihydrate)
|
Azik
|
500mg
|
Film-Coated Tablet
|
ANTIBACTERIAL (MACROLIDE)
|
Kusum Healthcare Private Limited
|
India
|
Automatic Renewal
|
21 September 2021
|
13 November 2026
|
View |
DR-XY43863_PI_01.pdf
|
DR-XY43863
|
Tadalafil
|
Cialis
|
5 mg
|
Film-Coated Tablet
|
Phosphodiesterase Type-5 Inhibitor
|
Lilly del Caribe, Inc.
|
United States of America
|
Initial (from Monitored release)
|
06 June 2022
|
22 April 2026
|
View |
DR-XY43865_PI_01.pdf
|
DR-XY43865
|
Indacaterol (as maleate) + Glycopyrronium (as bromide)
|
Ultibro Breezhaler
|
110 mcg/50 mcg
|
Powder for Inhalation in Hard Capsule
|
-
|
Siegfried Barbera, S.L.
|
Spain
|
Initial (Variation)
|
27 May 2022
|
27 May 2027
|
View |
|
DR-XY43877
|
Levofloxacin (as Hydrochloride)
|
Levoxol
|
100mg/mL
|
Solution For Injection (Iv)
|
Antibacterial (Fluoroquinolone)
|
Cisen Pharmaceutical Co., Ltd
|
China
|
Renewal
|
02 November 2024
|
17 November 2029
|
View |
|
DR-XY43891
|
Dobutamine (as Hydrochloride)
|
Dobugen
|
50mg/mL (250mg/5mL)
|
Solution For Injection (Iv)
|
Adrenergic Agent
|
Celogen Pharma Pvt. Ltd.
|
India
|
Renewal
|
31 May 2024
|
18 November 2029
|
View |
|
DR-XY43892
|
Mesalazine
|
Pentasa
|
1 g
|
Prolonged-Release Tablet
|
Bowel Anti-inflammatory
|
Ferring International Center S.A.
|
Switzerland
|
Renewal
|
16 June 2024
|
14 November 2029
|
View |
|
DR-XY43894
|
Teicoplanin
|
Teicotan 200
|
200 mg
|
Lyophilized Powder for Injection (IM/IV)
|
Antibacterial
|
Gufic Biosciences Ltd.
|
India
|
Renewal
|
04 September 2024
|
13 November 2029
|
View |
|
DR-XY43895
|
Cefpirome (as sulfate)
|
Zefrome
|
1g
|
Powder For Injection (Iv)
|
-
|
Sichuan Pharmaceutical Inc.
|
China
|
-
|
03 January 2020
|
19 December 2024
|
View |
|
DR-XY43897
|
Ketorolac Trometamol
|
Ketorobas
|
30 mg/Ml
|
Solution For Injection (I.M./I.V.)
|
-
|
Friends Pharma (Pvt) Ltd.
|
Pakistan
|
-
|
24 June 2020
|
26 November 2024
|
View |
|
DR-XY43899
|
Paracetamol
|
Paragesic
|
500 mg
|
Suppository
|
Analgesic /Antipyretic
|
Bliss GVS Pharma Ltd.
|
India
|
Renewal
|
07 October 2024
|
13 November 2029
|
View |
|
DR-XY43912
|
Celecoxib
|
Rifoxib
|
200 mg
|
Capsule
|
-
|
Lloyd Laboratores, Inc.
|
Philippines
|
-
|
27 May 2020
|
01 December 2024
|
View |
|
DR-XY43916
|
Clobetasol Propionate
|
None
|
500mcg/ g (0.05%w/w)
|
Cream
|
Anti-inflammatory/Anti-pruritic
|
DS Cosmeceutical Manufacturing Laboratory
|
Philippines
|
Automatic Renewal
|
15 September 2021
|
25 November 2026
|
View |
|
DR-XY43919
|
Atorvastatin (as calcium)
|
Caliptrol
|
20 mg
|
Film-Coated Tablet
|
Antihyperlipidemic
|
Ferozsons Laboratories, Limited
|
Pakistan
|
Renewal
|
25 July 2024
|
21 November 2029
|
View |
|
DR-XY43920
|
Atorvastatin (as calcium)
|
Caliptrol
|
10 mg
|
Film-Coated Tablet
|
Antihyperlipidemic
|
Ferozsons Laboratories, Limited
|
Pakistan
|
Renewal
|
04 August 2024
|
21 November 2029
|
View |
|
DR-XY43923
|
Paclitaxel
|
Vexel-300
|
6mg/mL (300mg/50mL)
|
Concentrate For Solution For Iv Infusion
|
Antineoplastic
|
Admac Lifesciences
|
India
|
Renewal
|
29 February 2024
|
01 December 2029
|
View |
|
DR-XY43926
|
Dutasteride
|
Dugen
|
500 mcg
|
Film- Coated Tablet
|
-
|
Sydler Remedies Pvt. Ltd.
|
India
|
-
|
19 September 2019
|
01 December 2024
|
View |
|
DR-XY43932
|
Co-Amoxiclav
|
Unbranded
|
625mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
04 August 2024
|
02 December 2029
|
View |
|
DR-XY43934
|
Sodium Valproate + Valproic Acid (As Sodium Valproate)
|
Encorate Chrono 500
|
333mg/145mg
|
Controlled-Release Tablet
|
-
|
Sun Pharmaceutical Industries Ltd.
|
India
|
-
|
28 January 2020
|
02 December 2024
|
View |
|
DR-XY43935
|
Mecobalamin
|
Zecobal
|
500 mcg
|
Film-Coated Tablet
|
Hematinic
|
The Schazoo Pharmaceutical Laboratories (Pvt) Ltd.
|
Pakistan
|
Renewal
|
20 October 2024
|
02 December 2029
|